NCT07255755 (REACT) is a NA clinical trial of American Ginseng extract in Attention, sponsored by University of East Anglia.

Who is sponsoring NCT07255755?

NCT07255755 is sponsored by University of East Anglia.

What drugs are being tested in NCT07255755?

Interventions in NCT07255755: American Ginseng extract, Placebo product.

What condition does NCT07255755 study?

NCT07255755 studies Attention, Cognition.

Is NCT07255755 still recruiting?

NCT07255755 is currently recruiting now. Last updated 1 December 2025.

Last reviewed 2025-12-01 · How we verify

NCT07255755: REACT

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

A Double Blind Randomised Clinical Study to Evaluate Attention Improvement in an Adult Population After Cereboost Intake

Recruiting now NA Last updated 1 December 2025

What this trial tests

NA trial testing American Ginseng extract in Attention in 200 participants. Currently enrolling.

Timeline

1 December 2025

Primary endpoint
1 January 2027

1 January 2027

Quick facts

Lead sponsor	University of East Anglia
Phase	NA
Status	Recruiting now
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	triple
Primary purpose	supportive care
Enrollment	200
Start date	1 December 2025
Primary completion	1 January 2027
Estimated completion	1 January 2027
Sites	2 locations across United Kingdom

Drugs / interventions tested

American Ginseng extract
Placebo product

Conditions studied

Attention — all drugs for Attention →
Cognition — all drugs for Cognition →

Sponsor

University of East Anglia

Who can join

Adults 18 to 40, any sex, with Attention or Cognition. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Measure of Attention
Time frame: Baseline, 2-hours, 4-hours and 6-hours post intervention
Measured by the Attentional Network Task (ANT), expressed by accuracy score (%correct) at 6 hours post consumption

Sponsor's own description

The study will assess the immediate, short-term benefits of a single dose of a supplement containing 200mg of Panax quinquefolius (American Ginseng) on cognition (brain function) in healthy young adults. To understand the effect this product may have, the participants will complete a series of questionnaires and cognitive tests (tests of memory and brain function) at set intervals across a 6-hour period. Blood samples will also be collected to assess the impact of the study product on the participants.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Attention

Currently open trials in the same condition.

NCT07266909 — Impact of Attentional Tunelling on a Population of French Practitioners · recruiting
NCT07408180 — Exploratory Randomized, Controlled, Dose-response Study on the Impact of Nicotine From Five Variants of a Nicotine Table · NA · active not recruiting
NCT06837246 — A Clinical Trial to Assess Cognitive Effects of Cognitive Nutritional Supplement in General Population · NA · recruiting
NCT06587113 — An Investigation of Attentional and Inhibitory Processes During Active Visual Search in Humans · NA · recruiting
NCT06248268 — Neuropsychological Patterns of Suicide Ideators and Suicide Attempters · recruiting

Other University of East Anglia trials

Trials by the same sponsor.

NCT07512388 — Acceptance and Commitment Therapy for Post-Stroke Adjustment Via Telerehabilitation · NA · active not recruiting
NCT06733103 — Pilot of Cognitive Stimulation Therapy for Pre-frail Stroke Survivors · NA · completed
NCT06971718 — Coronary Bifurcations With Ischaemia and Flow Assessment · recruiting
NCT05928104 — Optimising Pharmacist-led Medication Reviews in Primary Care · completed
NCT06451965 — SCED - Wisdom Enhancement for Post-Stroke Depression · NA · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT07255755 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by University of East Anglia
Last refreshed: 1 December 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07255755.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing